ruiqi (mosapride citrate tablets)-比较正规的买球软件

中

about us
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
- founded in 1995, hansoh is a leading r&d-driven pharmaceutical company in china.
news
- company news
- media focus
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
- with the objective of 'creating excellence in china's pharmaceuticals and add momentum to "made in china"',hansoh endeavors to make its own contribution to the “healthy china 2030” master plan.
products
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
- hansoh is committed to innovation and research in the six therapeutic areas, including cns, oncology, anti-infectives, diabetes, gastrointestinal, and cardiovascular. constantly evolving, hansoh makes every effort to forage itself to be a market-leading and world-renowned pharmaceutical company.
r&d
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
- hansoh has been holding on to the strategy of technology and innovation, and established r&d centers located in lianyungang and shanghai.
services
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate marketing systems
- hansoh pursuits the philosophy of “professional marketing of medical products for benefits of all doctors and patients” to actively carry out national policies and establish innovate
contact us
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.
- hansoh sticks to providing “attractive career opportunities, cohesive corporate culture, continuous learning and incentive mechanism” so that employees can have clear career path for both administrative ranks and technical titles.

ruiqi (mosapride citrate tablets)

mosapride citrate tablets

english name: mosapride citrate tablets

chinese pinyin: juyuansuan moshabili pian

the active ingredient of this product is mosapride citrate.

chemical name: 4-amino-5-chloro-2-ethoxy-n-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide citrate dihydrate

/en/upload/images/2017/06/06/2026d53155054a74b132c6f4491d135d.png

【name】	common name: mosapride citrate tablets brand name: rui qi english name: mosapride citrate tablets chinese pinyin: juyuansuan moshabili pian
【ingredients】	the active ingredient of this product is mosapride citrate. chemical name: 4-amino-5-chloro-2-ethoxy-n-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide citrate dihydrate structural formula: molecular formula: c₂₁h₂₅clfn₃o₃•c₆h₈o₇•2h₂o molecular weight: 650.05
【description】	this product is a white or off-white film-coated tablet, which is white or off-white after removal of the film
【indications】	this product is gastro intestinal prokinetic agents (gipa), mainly used for functional dyspepsia with heartburn, belching, nausea, vomiting, early satiety, upper abdominal distension and other gastrointestinal symptoms; also used for gastroesophageal reflux disease, diabetic gastroparesis and gastric dysfunction in patients with partial gastrectomy
【strength】	5mg（calculated on c₂₁h₂₅clfn₃o₃•c₆h₈o₇）
【dosage and administration】	oral, 5 mg (1 tablet) once, 3 times a day, taken before the meals.

1999: first-to-market generic drug in china

2001: included in the china spark program

2004: national key new product